Fenwick & West represented Elegen in the transaction. Elegen announced it raised $35 million in Series B Financing Round led by Triatomic Capital and was joined...
Elegen’s $35 Million Series B Financing Round
Knox Lane’s Partnership with All Star Healthcare Solutions
Kirkland & Ellis advised Knox Lane on the transaction, and McGuire Woods advised All Star Healthcare Solutions. Knox Lane, a growth-oriented investment firm, announced it has...
CCP Investments and Global Infrastructure Partners’ $6.2 Billion Acquisition of ALLETE
Skadden, Arps, Slate, Meagher & Flom advised ALLETE, Inc. on the transaction, while Kirkland & Ellis and Latham & Walkins advised the partnership led by Canada...
EQT’s $3 Billion Acquisition of Perficient
Simpson Thacher & Bartlett is advising an affiliate of BPEA Private Equity Fund VIII, part of EQT on the transaction, and Kirkland & Ellis is advising...
Zuora’s Acquisition of Togai
Freshfields Advises Zuora, Inc. on Its Acquisition of Togai Inc. Zuora, Inc., a leading monetization suite for modern businesses, has recently announced its strategic plan to...
Novavax’s $1.4 Billion Licensing Agreement with Sanofi
Ropes & Gray represented Novavax Inc. in the transaction. Novavax Inc.(Nasdaq: NVAX) announced it has entered into a co-exclusive licensing agreement with French pharmaceutical company Sanofi...
Block’s $2 Billion Senior Notes Offering
Wilson Sonsini Goodrich & Rosati advised Block on the offering, and Simpson Thacher & Bartlett advised the initial purchasers. Block, Inc. (NYSE: SQ) (“Block” or the...
Hilcorp Energy’s $500 Million Senior Notes Offering
Vinson & Elkins represented J.P. Morgan Securities LLC, as representative of the initial purchasers, in the offering. Hilcorp Energy I, L.P. announced its $500 million offering...
Axon’s Acquisition of Dedrone
Wilmer Cutler Pickering Hale and Dorr, Axinn, Veltrop & Harkrider and Tidal Partners advised Dedrone on the transaction, and Sullivan & Cromwell and Morgan, Lewis &...
Karyopharm’s Refinancing Transactions and Amended Royalty Agreement
Wilmer Cutler Pickering Hale and Dorr advised Karyopharm Therapeutics Inc. on the transactions. Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies,...
Corelight’s $150 Million Series E Funding Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Corelight in the transaction. Corelight, a leader in open network detection and response, announced it has secured $150...
Daré Bioscience’s $22 Million Non-Dilutive Strategic Royalty Financing
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Daré Bioscience, Inc. on the transaction, and Gibson, Dunn & Crutcher advised XOMA (US) LLC. Daré Bioscience, Inc....